CYP2C9 Genetic Polymorphisms and Warfarin

Clinical and Applied Thrombosis/Hemostasis - United States
doi 10.1177/107602960401000205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Genetic Polymorphisms in Warfarin and Tacrolimus-Related Genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot Population

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2014English

Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2016English

Erratum To: Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients

Molecular Diagnosis and Therapy
MedicineMolecular MedicineGeneticsPharmacology
2016English

CYP2C9 and OATP1B1 Genetic Polymorphisms Affect the Metabolism and Transport of Glimepiride and Gliclazide

Scientific Reports
Multidisciplinary
2018English

Influence of CYP2C9 and CYP2C19 Genetic Polymorphisms on Pharmacokinetics of Gliclazide MR in Chinese Subjects

British Journal of Clinical Pharmacology
Pharmacology
2007English

CYP2C9 Gene Analysis of Some Iranian Hypersensitive Patients to Warfarin

Pakistan Journal of Biological Sciences
AgronomyCrop Science
2009English

Genetic Warfarin Dosing

Journal of the American College of Cardiology
Cardiovascular MedicineCardiology
2011English

Combination Analysis in Genetic Polymorphisms of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese Population

International Journal of Medical Sciences
Medicine
2015English

In Vitro Inhibition of CYP2C9-Mediated Warfarin 7-Hydroxylation by Iguratimod

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy